Pyrethroid and bacteriocin mixture and use thereof

By combining insecticide mixtures of pyrethroids and pyrethroids, the problem of pyrethroid insecticide resistance is solved, efficient control of mosquitoes is achieved, and public health safety is ensured.

CN115768263BActive Publication Date: 2024-11-29VALENT BIOSCIENCES CORP
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202180034750.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-06-09
Publication Date
2024-11-29
Estimated Expiration
2041-06-09

AI Technical Summary

Technical Problem

The existing pyrethroid pesticides are gradually ineffective due to resistance problems, posing a threat to public health and lack effective alternatives.

Method used

Using an insecticidal mixture, including one or more methocin (such as avermectin, ivermectin) and one or more pyrethroids (such as cyanthrin, permethrin, pyrethrin) and a combination of C8, 9, and 10 fatty acids for controlling mosquitoes.

Benefits of technology

The mixture exhibits high mortality rates against mosquitoes, including strains known to be resistant to pyrethroids or methin alone, providing effective mosquito control, delaying resistance development and ensuring public health security.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003938458830000031
    Figure BDA0003938458830000031
  • Figure BDA0003938458830000041
    Figure BDA0003938458830000041
  • Figure BDA0003938458830000042
    Figure BDA0003938458830000042
Patent Text Reader

Abstract

The present invention relates to an insecticidal mixture comprising one or more mycotoxin and one or more pyrethroids. The present invention also relates to a method for controlling pests, comprising applying the mixture of the present invention to an area where pest control is desired.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to an insecticidal mixture comprising one or more mycotoxin and one or more pyrethroids. The present invention also relates to a method for controlling pests, comprising applying the mixture of the present invention to an area where pest control is desired. Background Art

[0002] Arthropods, such as mosquitoes, are often a nuisance to humans and other animals. Arthropods can also be vectors of disease. Because of nuisance and public health concerns, humans strive to control arthropod populations near their environment. One method of controlling arthropods is the use of pyrethroids.

[0003] Pyrethroids are axonal excitotoxins that prevent the closure of voltage-gated sodium channels in the axonal membranes of arthropods. The toxins act by paralyzing the organism.

[0004] Although pyrethroids are effective arthropod insecticides, a major concern is that arthropod populations are developing resistance to them. Pyrethroid resistance caused by specific detoxification enzymes or altered target site mechanisms (knockdown resistance ("KDR") type mutations in sodium channels) has been reported in most medically important mosquito species in most continents. If resistance continues to develop and spread at its current rate, it could render these insecticides ineffective in their current form. Such a scenario could have devastating consequences for public health, as many pyrethroids currently have no obvious alternatives.

[0005] Resistance is a complex phenomenon that develops as a result of exposure to the same or similar classes of insecticides over multiple insect generations. Resistance develops as a result of the extinction of sensitive individuals in a population and the subsequent survival of reproducing individuals that are inherently "immune" to the effects of the insecticide. Resistance may be due to a variety of factors, including selection for target site mutations, detoxification enzymes, and reduced cuticular penetration. Resistance may arise in naive populations previously identified as sensitive to the insecticide, or in populations that have been exposed to insecticides of other or similar classes or modes of action. Cross-resistance may occur, and behavioral resistance mechanisms may exist in addition to physiological resistance. The net result of resistance to current control measures is that existing insecticides are often inadequate to provide the mortality required to achieve adequate levels of arthropod control at environmentally acceptable application rates. Because pyrethroid-resistant insects pose a significant risk to human health, there is a need in the art for safe and effective arthropod insecticides.

[0006] Streptomycin is a naturally occurring 16-membered macrolide derivative produced as a fermentation product of Streptomyces avermitilis. Streptomycin exists as 4 specific homologues, including mixtures of major and minor components. Synthetic streptocins include, but are not limited to, ivermectin, avermectin, selamectin, doramectin, emamectin, lepidin and ecrimycin. Natural streptocins and their synthetic derivatives are known to control worms and insects.

[0007] One arthropod that is a major health problem is the mosquito. The three main genera of mosquitoes that transmit disease are Anopheles, Culex, and Aedes. Therefore, mosquito control is necessary to reduce disease transmission.

[0008] Different insecticides can attack at different stages of the insect's development. However, it is the adult stage of the mosquito that transmits the viruses and parasites that cause disease. Controlling the larval stage is the first line of defense in suppressing mosquito populations, but without the ability to control adult mosquitoes, the ability to control disease in many settings could be severely compromised.

[0009] U.S. Patent No. 9,826,742 relates to an insecticide mixture of pyrethroids and fatty acids, with octanoic acid, nonanoic acid, and decanoic acid in a ratio of 1:1:1. While this mixture successfully controlled Aedes aegypti mosquitoes that were known to be resistant only to pyrethroids, there is no guarantee that Aedes aegypti mosquitoes will not develop resistance to this mixture in the future.

[0010] Therefore, there is a need in the art for additional insecticide mixtures that are effective against pyrethroids and pyrethroid-susceptible arthropods. Summary of the invention

[0011] In one aspect, the invention is directed to an insecticidal mixture comprising one or more mycotoxin and one or more pyrethroids.

[0012] In a preferred aspect, the present invention relates to an insecticidal mixture comprising one or more bacteriocins selected from avermectin and ivermectin and one or more pyrethroids selected from cypermethrin, permethrin and pyrethrum, and optionally C8, 9, 10 fatty acids.

[0013] In another aspect, the present invention relates to a method of controlling mosquitoes, comprising applying an effective amount of the mixture of the present invention to mosquitoes or to an area where mosquito control is desired.

[0014] In another aspect, the present invention relates to a method for controlling mosquitoes, comprising sequentially or simultaneously applying an effective amount of one or more bacteriocins selected from avermectin and ivermectin and an effective amount of one or more pyrethroids selected from cypermethrin, permethrin and pyrethrum to mosquitoes or areas where mosquitoes need to be controlled. DETAILED DESCRIPTION

[0015] Applicants have found that mixtures of one or more pyrethroids and one or more pyrethroids are very effective in controlling insect pests, especially mosquitoes. Application of the mixture of the present invention provides high mortality rates for arthropods, including strains known to be resistant to pyrethroids or pyrethroids alone.

[0016] In one embodiment, the present invention is directed to an insecticidal mixture comprising one or more pyrethroids and one or more mycotoxins.

[0017] In a preferred embodiment, the present invention relates to an insecticidal mixture comprising one or more insecticides selected from avermectin and ivermectin and one or more pyrethroids selected from cypermethrin, permethrin and pyrethrum, and optionally C8, 9, 10 fatty acids.

[0018] As used herein, the term "bacteriocin" includes compounds of formula (I):

[0019] in:

[0020] R1 Free The group composed of;

[0021] R2 is selected from hydroxyl and imine, preferably oxime, more preferably ketoxime, most preferably

[0022] R3 and R4 are each independently selected from C2-C6 alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, cycloalkynyl and aryl, preferably The group composed of.

[0023] In a preferred embodiment, the one or more bacteriocins are selected from the group consisting of those compounds in Table 1 below.

[0024] Table 1

[0025]

[0026]

[0027] In another preferred embodiment, the one or more streptococci are selected from the group consisting of avermectin, avermectin including avermectin B1a and avermectin B1b, selamectin, domamicin, ivermectin including ivermectin B1a and ivermectin B1b, emamectin including emamectin B1a and emamectin B1b, lepemectin and epromectin including epromectin B1a and epromectin B1b. In a more preferred embodiment, the one or more streptococci are ivermectin or avermectin. In another embodiment, the mixture of the present invention does not contain avermectin.

[0028] As used herein, the term "pyrethroid" includes compounds of formula (II), (III), (IV) and (V):

[0029]

[0030] in:

[0031] R1 is selected from CH3, CF3, Br, Cl and The group composed of;

[0032] R2 is selected from the group consisting of H, CH3, Br and Cl;

[0033] R3 choose freedom the group formed; and

[0034] R4 Free The group composed of;

[0035]

[0036] in:

[0037] R choose freedom The group composed of;

[0038]

[0039] in:

[0040] R1 Free The group composed of;

[0041] R2 is as well as

[0042] R3 is as well as

[0043]

[0044] in:

[0045] R1 is C or Si;

[0046] R2 is O or CH2; and

[0047] R3 is H or F.

[0048] In a preferred embodiment, the one or more pyrethroids are selected from the group consisting of those compounds in Tables 2-5 below.

[0049] Table 2

[0050]

[0051]

[0052]

[0053] Table 3

[0054]

[0055]

[0056] Table 4

[0057]

[0058]

[0059] Table 5

[0060]

[0061] Compound <![CDATA[R1]]> <![CDATA[R2]]> <![CDATA[R3]]> Ethofenprox C O H Fluosimethrin Si <![CDATA[CH2]]> F

[0062] In a preferred embodiment, one or more pyrethroids are selected from the group consisting of allethrin, bifenthrin, β-cyhalothrin, flucythrin, cypermethrin, d, d, trans-cypermethrin, cypermethrin, deltamethrin, cis-cypermethrin, ethothrin, cypromethrin, cypermethrin, flucythrin, T-cypermethrin, λ-cyhalothrin, γ-cyhalothrin, imithrin, methicillin, 1RS cis-permethrin, permethrin, prallethrin, pyrethrin, resmethrin, silafluthrin, phenothrin (d-phenothrin), tefluthrin, tetramethrin, tralomethrin, transfluthrin and ζ-cypermethrin. In a more preferred embodiment, one or more pyrethroids are cypromethrin. In another embodiment, one or more pyrethroids do not include pyrethrins. In another embodiment, the mixture of the present invention does not contain gamma-cyhalothrin or bifenthrin.

[0063] As used herein, the term "pyrethrin" refers to a composition including pyrethrins (including pyrethrin I and pyrethrin II) and pyrethrins (including pyrethrin I and pyrethrin II).

[0064] As used herein, the term "C8,9,10 fatty acids" refers to a mixture of caprylic, nonanoic, and capric fatty acids. Caprylic acid or caprylic acid is an eight-carbon saturated fatty acid. Nonanoic acid or nonanoic acid is a nine-carbon saturated fatty acid. Capric acid or capric acid is a ten-carbon saturated fatty acid. C8,9,10 fatty acids have equal amounts of each fatty acid by weight percentage (about 33.3% each).

[0065] In another preferred embodiment, the ratio of one or more pyrethroids to one or more bacteriocins is from about 1000:1 to about 1:1000, preferably from about 100:1 to about 1:100, more preferably from about 50:1 to 1:50, even more preferably from about 20:1 to about 1:20, even more preferably from about 10:1 to about 1:10, more preferably from about 5:1 to about 1:5, more preferably from about 2.6:1 to about 1:2, more preferably from about 1.3:1 to about 1:1.3 and even more preferably about 1.3:1 or 2.6:1.

[0066] In another embodiment, the ratio of one or more pyrethroids to one or more bacteriocins is from about 1000:1 to about 1.1:1, preferably from about 100:1 to about 1.1:1, more preferably from about 50:1 to about 1.1:1, even more preferably from about 20:1 to about 1.1:1, even more preferably from about 10:1 to about 1.1:1, more preferably from about 5:1 to about 1.1:1, more preferably from about 3.3:1 to about 1.1:1, still more preferably from about 2.67:1 to about 1.1:1, even more preferably from about 2:1 to about 1.1:1, still more preferably from about 1.3:1 to about 1.1:1, and most preferably from about 3.3:1 to about 1.3:1.

[0067] In another embodiment, the ratio of one or more pyrethroids to one or more bacteriocins is from about 1:1.1 to about 1:1000, preferably from about 1:1.1 to about 1:100, more preferably from about 1:1.1 to about 1:50, even more preferably from about 1:1.1 to about 1:20, still more preferably from about 1:1.1 to about 1:10, even more preferably from about 1:1.1 to about 1:5, even more preferably from about 1:1.1 to about 1:2, even more preferably from about 1:1.1 to about 1:1.3. In another embodiment, the ratio of one or more pyrethroids to one or more bacteriocins is about 1.33:1 or about 1:1.1. The ratio of one or more pyrethroids to one or more bacteriocins is based on a weight ratio.

[0068] In another preferred embodiment, the ratio of one or more pyrethroids to C8, 9, 10 fatty acids is from about 1000: 1 to about 1: 1000, preferably from about 100: 1 to about 1: 100, more preferably from about 50: 1 to 1: 50, even more preferably from about 20: 1 to about 1: 20, still more preferably from about 10: 1 to about 1: 10, still more preferably from about 5: 1 to about 1: 5, still more preferably from about 2: 1 to about 1: 2, and even more preferably from about 1.3: 1 to about 1: 1.3.

[0069] In another embodiment, the ratio of one or more pyrethroids to C8, 9, 10 fatty acids is from about 1000: 1 to about 1.1: 1, preferably from about 100: 1 to about 1.1: 1, more preferably from about 50: 1 to about 1.1: 1, even more preferably from about 20: 1 to about 1.1: 1, still more preferably from about 10: 1 to about 1.1: 1, still more preferably from about 5: 1 to about 1.1: 1 and even more preferably from about 5: 1 to about 4: 1.

[0070] In another embodiment, the ratio of one or more pyrethroids to C8, 9, 10 fatty acids is from about 1: 1.1 to about 1: 1000, preferably from about 1: 1.1 to about 1: 100, more preferably from about 1: 1.1 to about 1: 50, even more preferably from about 1: 1.1 to about 1: 20, still more preferably from about 1: 1.1 to about 1: 10, still more preferably from about 1: 1.1 to about 1: 5, still more preferably from about 1: 1.1 to about 1: 2, even more preferably from about 1: 1.1 to about 1: 1.3. In another embodiment, the ratio of one or more pyrethroids to C8, 9, 10 fatty acids is or about 1: 1. The ratio of one or more pyrethroids to C8, 9, 10 fatty acids is based on a weight ratio.

[0071] In another preferred embodiment, the ratio of one or more bacteriocins to C8, 9, 10 fatty acids is from about 1000: 1 to about 1: 1000, preferably from about 100: 1 to about 1: 100, more preferably from about 50: 1 to 1: 50, even more preferably from about 20: 1 to about 1: 20, still more preferably from about 10: 1 to about 1: 10, still more preferably from about 5: 1 to about 1: 5, still more preferably from about 2: 1 to about 1: 2, and even more preferably from about 1.3: 1 to about 1: 1.3.

[0072] In another embodiment, the ratio of one or more bacteriocins to C8, 9, 10 fatty acids is from about 1000: 1 to about 1.1: 1, preferably from about 100: 1 to about 1.1: 1, more preferably from about 50: 1 to about 1.1: 1, even more preferably from about 20: 1 to about 1.1: 1, still more preferably from about 10: 1 to about 1.1: 1, still more preferably from about 5: 1 to about 1.1: 1, still more preferably from about 2: 1 to about 1.1: 1, even more preferably from about 1.5: 1 to about 1.1: 1.

[0073] In another embodiment, the ratio of one or more bacteriocins to C8, 9, 10 fatty acids is about 1: 1.1 to about 1: 1000, preferably about 1: 1.1 to about 1: 100, more preferably about 1: 1.1 to about 1: 50, even more preferably about 1: 1.1 to about 1: 20, still more preferably about 1: 1.1 to about 1: 10, still more preferably about 1: 1.1 to about 1: 5, still more preferably about 1: 1.1 to about 1: 2, even more preferably about 1: 1.1 to about 1: 1.3. In another embodiment, the ratio of one or more bacteriocins to C8, 9, 10 fatty acids is about 1.5: 1. The ratio of one or more bacteriocins to C8, 9, 10 fatty acids is based on a weight ratio.

[0074] In another preferred embodiment, the ratio of one or more pyrethroids to one or more bacteriocins to C8, 9, 10 fatty acids is from about 1000:1:1 to about 1:1:1000 or from about 1000:1:1 to about 1:1000:1 or from about 1:1000:1 to about 1:1:1000 or from about 1000:1000:1 to about 1:1000:1000 or from about 1000:1000:1 to about 1:1000:1000 or from about 1000:1000:1 to about 1:1000:1000 or from about 1000:1000:1 to about 1:1000:1000, preferably from about 100:1:1 to about 1:1:100 or from about 100:1:1 to about 1:100:1 or from about 100:1:1 to about 1:100:1 or from about 1:100:1 to about 1:100:1 :1 to about 1:1:100 or about 100:100:1 to about 1:100:100 or about 100:100:1 to about 100:1:100 or about 100:1:100 to about 1:100:100, more preferably about 50:1:1 to about 1:1:50 or about 50:1:1 to about 1:50:1 or about 1:50:1 to about 1:1:50 or about 50:50:1 to about 1:50:50 or about 50:50:1 to about 1:50:50 or about 50:1:50 to about 1:50:50, even more preferably about 20:1:1 to about 1:1:20 or about 20:1:1 to about 1:20:1 or about 1:20:1 to about t 1:1:20 or about 20:20:1 to about 1:20:20 or about 20:20:1 to about 20:1:20 or about 20:1:20 to about 1:20:20, even more preferably about 10:1:1 to about 1:1:10 or about 10:1:1 to about 1:10:1 or about 1:10:1 to about 1:1:10 or about 10:10:1 to about 1:10:10 or about 10:10:1 to about 10:1:10 or about 10:1:10 to about 1:10:10, even more preferably From about 5:1:1 to about 1:1:5 or from about 5:1:1 to about 1:5:1 or from about 1:5:1 to about 1:1:5 or from about 5:5:1 to about 1:5:5 or from about 5:5:1 to about 1:5:5 or from about 5:5:1 to about 1:5:5 or from about 5:1:5 to about 1:5:5, even more preferably from about 2:1:1 to about 1:1:2 or from about 2:1:1 to about 1:2:1 or from about 1:2:1 to about 1:1:2 or from about 2:2:1 to about 1:2:2 or from about 2:2:1 to about 2:1:2 or from about 2:1:2 to about 1:2:2. In a most preferred embodiment, the ratio of one or more pyrethroids to one or more bacteriocins to C8, 9, 10 fatty acids is from about 5:1.5:1 to about 2:1.5:1. The ratio of one or more pyrethroids to one or more bacteriocins to C8, 9, 10 fatty acids is based on a weight ratio.

[0075] In a more preferred embodiment, the present invention relates to an insecticidal mixture comprising abamectin and cypermethrin, preferably the weight ratio of abamectin to cypermethrin is about 1:1.33 or about 1:2.67.

[0076] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising abamectin and permethrin, preferably, the weight ratio of abamectin to permethrin is about 1:3.33.

[0077] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising abamectin and pyrethrin, preferably the weight ratio of abamectin to pyrethrin is about 1:3.33.

[0078] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising ivermectin and cypermethrin, preferably the weight ratio of ivermectin to cypermethrin is about 1:1.33 or about 1:2.67.

[0079] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising ivermectin and permethrin, preferably in a weight ratio of ivermectin to permethrin of about 1:3.33.

[0080] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising ivermectin and pyrethrin, preferably the weight ratio of ivermectin to pyrethrin is about 1:3.33.

[0081] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising abamectin, cypermethrin and C8, 9, 10 fatty acids, preferably a weight ratio of abamectin to cypermethrin of about 1.5:2:1 or about 1.5:4:1 to C8, 9, 10 fatty acids.

[0082] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising abamectin, permethrin and C8, 9, 10 fatty acids, preferably a weight ratio of abamectin to permethrin to C8, 9, 10 fatty acids is about 1.5:5:1.

[0083] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising abamectin, pyrethrin and C8, 9, 10 fatty acids, preferably a weight ratio of abamectin to pyrethrin to C8, 9, 10 fatty acids is about 1.5:5:1.

[0084] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising ivermectin, cypermethrin and C8, 9, 10 fatty acids, preferably, the weight ratio of ivermectin to cypermethrin to C8, 9, 10 fatty acids is about 1.5:2:1 or about 1.5:4:1.

[0085] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising ivermectin, permethrin and C8, 9, 10 fatty acids, preferably the weight ratio of ivermectin to permethrin to C8, 9, 10 fatty acids is about 1.5:5:1.

[0086] In another more preferred embodiment, the present invention relates to an insecticidal mixture comprising ivermectin, pyrethrin and C8, 9, 10 fatty acids, preferably the weight ratio of ivermectin to pyrethrin to C8, 9, 10 fatty acids is about 1.5:5:1.

[0087] In another embodiment, one or more of the present invention's bacteriophages may be present in an effective amount in the composition. In a preferred embodiment, the effective amount of one or more pyrethroids is from about 0.1% to about 50% w / w, preferably from about 0.1% to about 10% w / w, even more preferably from about 0.1% to about 5% w / w, more preferably from about 1% to about 3% w / w, and still more preferably at a concentration of about 1.5% w / w.

[0088] In another embodiment, one or more pyrethroids of the present invention may be present in the composition in an effective amount. In a preferred embodiment, the effective amount of one or more pyrethroids is from about 0.1% to about 50% w / w, preferably from about 0.1% to about 10% w / w, even more preferably from about 0.1% to about 5% w / w, more preferably from about 2% to about 5% w / w, still more preferably at a concentration of about 2.0%, 4.0% or about 5.0% w / w.

[0089] In another embodiment, the C8, 9, 10 fatty acids of the present invention may be present in the composition in an effective amount. In a preferred embodiment, the effective amount of the C8, 9, 10 fatty acids is from about 0.1% to about 50% w / w, preferably from about 0.1% to about 10% w / w, even more preferably from about 0.1% to about 10% w / w, more preferably from about 0.1% to about 5% w / w, and still more preferably at a concentration of about 1.0% w / w.

[0090] In another embodiment, the present invention is directed to a method of controlling pests comprising applying an effective amount of the mixture of the present invention to the pests or to an area in which pest control is desired.

[0091] In another embodiment, the present invention relates to a method for controlling mosquitoes, comprising sequentially or simultaneously applying an effective amount of one or more bacteriocins selected from avermectin and ivermectin and an effective amount of one or more pyrethroids selected from cypermethrin, permethrin and pyrethrin to mosquitoes or areas where mosquitoes need to be controlled.

[0092] The mixture of the present invention can be applied by any convenient means. Those skilled in the art are familiar with modes of application, including but not limited to spraying, brushing, soaking, granular application, pressurized liquid (aerosol), spraying, bait and / or side dressing. Spraying includes space spraying. Space spraying includes aerosol and thermal mist spraying. Applying the mixture of the present invention to pests includes incorporating the mixture of the present invention into a composition that can be ingested by pests.

[0093] As used herein, "controlling" pests or "controlling" pests means eliminating, disabling, repelling or otherwise reducing the adverse effects of pests on plants or animals to a level desired by the grower, applicator or user.

[0094] As used herein, "area in need of pest control" means any area where pests are present in any life stage. Areas in need of pest control include, but are not limited to: a) plants and / or surrounding soil on which pests depend for survival; b) areas where plants are grown or harvested, or gardens, fields, greenhouses; c) indoor areas where humans live, such as residential buildings and commercial buildings, including single-family homes, hotels, daycare centers, libraries, multi-family homes, prisons, hotels, restrooms, corridors (including hotels and hospitals), or transportation; d) outdoor areas around human habitation, including areas near mosquito breeding sites and various indoor surfaces and structures, such as furniture including beds and furniture including books, etc.; e) fabrics, including tents, mosquito nets, clothes, etc.

[0095] Pests that can be controlled by the method of the present invention include, but are not limited to, arthropods. Arthropods include insects, centipedes, millipedes, and arachnids.

[0096] In one embodiment, the arthropod to be controlled is resistant to a pyrethroid or a mycotoxin.

[0097] In a preferred embodiment, the arthropod is an insect. In a more preferred embodiment, the insect is a mosquito. As used herein, "mosquito" refers to an insect belonging to the family Culicidae. Example subfamilies of mosquitoes include Anopheles and Culicininae. Example genera of mosquitoes include Anopheles, Culex, Aedes, Anopheles, Scaly, Trichodina, Cercospora, and Mansonia. Example species of mosquitoes include Aedes aegypti, Aedes albopictus, Aedes back, Aedes satarius (also known as black-spotted Aedes), Aedes vigilant (also known as agitating Aedes), Aedes short-stalked (also known as annoyed Aedes), Aedes true (also known as black Aedes), Aedes annoyed (also known as banded-proboscis), Aedes triserio, Leopard-footed mosquito, Aedes albopictus, Aedes, Anopheles gambiae including the subspecies Mopti and Savannah, Anopheles quadripunctata, Anopheles libertaria, Anopheles darlingi, Anopheles pseudo-spotted, Anopheles albicans, Anopheles stephensi, Anopheles fornest, Anopheles nili, Anopheles coluzzii, Anopheles arabiensis, Anopheles mela, Culex quinquefasciatus, Culex pipiens acuminata (also known as Culex fatigued), Culex annularis, Culex residuum, Culex pipiens black, Culex salina, Culex pipiens pallens, Culex pipiens antennarius, Culex pipiens naivea, Trichodina nigrocaudatus, Trichodina columbia, Trichodina ciliata, C. pertubans, Mansonia africana, and Mansonia spp.

[0098] In a more preferred embodiment, the mosquito belongs to a genus selected from the group consisting of Culex, Aedes, Anopheles, and combinations thereof. In an even more preferred embodiment, the mosquito belongs to a genus selected from the group consisting of Culex, Aedes, and combinations thereof.

[0099] In an even more preferred embodiment, the mosquito is selected from the group consisting of Aedes aegypti, Culex pipiens fivestripes, Anopheles quadrimaculatus, and combinations thereof. In an even more preferred embodiment, the mosquito is Aedes aegypti or Culex pipiens fivestripes.

[0100] In another embodiment, the mixtures of the present invention provide initial arthropod control.In another embodiment, the mixtures of the present invention provide residual arthropod control.

[0101] In another embodiment, the one or more bacteriocins may be applied at about 0.01 to about 100 grams per hectare ("g / HA"), preferably about 0.1 to about 100 g / HA, more preferably about 0.1 to about 10 g / HA, even more preferably about 0.1 to about 5 g / HA, even more preferably about 0.1 to about 2 g / HA, still more preferably about 0.5 to about 2 g / HA, even more preferably about 0.75 to about 1.5 g / HA, even more preferably about 1 g / HA.

[0102] In another embodiment, the one or more pyrethroids may be applied at about 0.01 to about 100 grams per hectare ("g / HA"), preferably about 0.1 to about 100 g / HA, more preferably about 0.1 to about 10 g / HA, even more preferably about 0.1 to about 5 g / HA, even more preferably about 1 to about 5 g / HA, still more preferably about 1 to about 4 g / HA, even more preferably about 2 to about 3 g / HA, even more preferably about 2.68 g / HA.

[0103] In another embodiment, the C8, 9, 10 fatty acids may be applied at about 0.01 to about 10 grams / hectare ("g / HA"), preferably about 0.01 to about 1 g / HA, more preferably about 0.1 to about 1 g / HA, even more preferably about 0.4 to about 0.9 g / HA, even more preferably about 0.5 to about 0.8 g / HA, even more preferably about 0.6 to about 0.7 g / HA, and even more preferably about 0.67 g / HA.

[0104] As used herein, all numerical values ​​relating to amounts, weight percentages, etc. are defined as "about" or "approximately" each particular value, i.e., plus or minus 10%. For example, the phrase "about 5% w / w" should be understood to mean "from 4.5% to 5.5% w / w". Thus, amounts within 10% of the claimed value are included within the scope of the claims.

[0105] As used herein, "composition" refers to one or more active ingredients in a carrier. The carrier can be liquid, semi-solid, solid or gaseous and can contain additional ingredients. For example, bait is a suitable carrier for the present invention.

[0106] The term "effective amount" refers to the amount of the mixture that will control the target pest. The "effective amount" will vary depending on factors such as the concentration of the mixture, the type of pest being treated, the severity of the pest infestation, the desired results, and the life stage of the pest during treatment. Therefore, it is not always possible to specify an exact "effective amount". However, in any individual case, an appropriate "effective amount" can be determined by one of ordinary skill in the art.

[0107] The articles "a", "an" and "the" are intended to include the plural as well as the singular, unless the context clearly indicates otherwise. For example, the method of the present invention is intended to control "pests", but this may include controlling multiple pests (e.g., more than one insect or more than one insect species or more than one mite or more than one mite species).

[0108] The disclosed embodiments are merely embodiments of the invention disclosed herein and are not to be considered limiting unless the claims explicitly state otherwise.

[0109] The following examples are intended to illustrate the invention and teach those of ordinary skill in the art how to use the formulations of the invention. They are not intended to be limiting in any way.

[0110] Example

[0111] Example 1 - Control of Aedes aegypti with a single KDR mutation by a mixture of cypermethrin and avermectin or ivermectin

[0112] method

[0113] In this bioassay, a wind tunnel bioassay was conducted in New Mexico in July 2017. Aedes aegypti mosquitoes known to be resistant (single knockdown resistance ("KDR") mutation) and susceptible to permethrin were used in the study. The following solutions were applied to adult Aedes aegypti mosquitoes: 1) 1.5% avermectin; 2) 1.5% ivermectin; 3) 2% cypermethrin; 4) a mixture of 2% cypermethrin and 1.5% avermectin; 5) a mixture of 2% cypermethrin and 1.5% avermectin; 6) a mixture of 2% cypermethrin and 1.5% ivermectin; 7) a mixture of 2% cypermethrin and 1.5% ivermectin.

[0114] To determine if a mixture provides an unexpected result, the observed combination efficacy ("OCE") was divided by the expected combination efficacy ("ECE"), where the expected ECE was calculated by the Abbott method:

[0115] ECE=A+B–(AB / 100)

[0116] Where ECE is the expected combined efficacy, and where A and B are the percentages of control given by the single active ingredients. If the ratio between the OCE of the mixture and the ECE of the mixture is greater than 1, there is a greater than expected interaction in the mixture. (Gisi, Synergistic Interaction of Fungicides in Mixtures, The American Phytopathological Society, 86: 11, 1273-1279, 1996). The results can be found in Table 6 below.

[0117] Table 6

[0118]

[0119] result

[0120] As shown in Table 6, both 1.5% avermectin and 1.5% ivermectin provided 100% control of Aedes aegypti mosquitoes known to be sensitive to permethrin.

[0121] In addition, with respect to Aedes aegypti, which is known to be resistant to permethrin, 1.5% avermectin provided 91% control, 1.5% ivermectin provided 64% control, and 2.0% cypermethrin provided 76% control. When cypermethrin was mixed with avermectin or ivermectin, control was enhanced. Specifically, a mixture of 2.0% cypermethrin and 1.5% avermectin or a mixture of 2.0% cypermethrin and 1.5% ivermectin provided 100% control. For the mixture of ivermectin and cypermethrin, this control was enhanced to an unexpected level. Specifically, the mixture of ivermectin and cypermethrin provided an OCE:ECE ratio of 1.1.

[0122] Example 2 - Control of Aedes aegypti with double KDR mutation by a mixture of cypermethrin and avermectin

[0123] method

[0124] In this bioassay, a wind tunnel bioassay was conducted in New Mexico in January 2020. Aedes aegypti mosquitoes known to be resistant (double knockdown resistance ("KDR") mutation) and sensitive to permethrin were used in the study. The following solution was applied to adult Aedes aegypti mosquitoes: 4% cypermethrin, 1.5% avermectin, and a mixture of 1% C8, 9, 10 fatty acids. The percentage mortality was recorded at 15 minutes ("Min"), 1 hour ("Hr"), 24 hours, and 48 hours. The results are shown in Table 7 below.

[0125] Table 7

[0126]

[0127] result

[0128] As seen in Table 7, application of a mixture of 4% cypermethrin, 1.5% avermectin, and 1% C8,9,10 fatty acids resulted in 92% control of Aedes aegypti with double KDR mutations after 48 hours. This result was surprising because Aedes aegypti with double KDR mutations were 10 times more resistant to pyrethroids than single KDR mutants.

[0129] Example 3 - Control of Culex pipiens by a mixture of cypermethrin and avermectin or ivermectin

[0130] method

[0131] In this bioassay, a wind tunnel bioassay was conducted in New Mexico in August 2019. Culex pipiens pipiens, known to be resistant and sensitive to permethrin, was used in the study. The following solutions were applied to adult Culex pipiens pipiens: 1) a mixture of 2% cypermethrin, 1.5% ivermectin, and 1% C8,9,10 fatty acids; 5) a mixture of 4% cypermethrin, 1.5% avermectin, and 1% C8,9,10 fatty acids; 6) a mixture of 4% cypermethrin, 1.5% ivermectin, and 1% C8,9,10 fatty acids. The percentage mortality was recorded at 15 minutes, 1 hour, 24 hours, and 48 hours. The results can be found in Table 8 below.

[0132] Table 8

[0133]

[0134] result

[0135] As shown in Table 8 above, application of a mixture of 2% or 4% cypermethrin, 1.5% avermectin or ivermectin, and 1% C8,9,10 fatty acids resulted in 100% control of Culex pipiens known to be resistant to permethrin within about 1 hour. This control was maintained after 48 hours. This result is important because resistant strains of Culex pipiens are metabolically resistant to pyrethroids. Specifically, when permethrin was applied to resistant strains of Culex pipiens, the mosquitoes were shown to be controlled after 1 hour, but woke up about 48 hours later after they metabolized the permethrin.

[0136] Example 4 - Control of Culex pipiens quinquefasciatus by a mixture of permethrin and avermectin or ivermectin

[0137] method

[0138] In this bioassay, a wind tunnel bioassay was conducted in New Mexico in March 2020. Culex pipiens pipiens, known to be resistant and sensitive to permethrin, was used in the study. The following solutions were applied to adult Culex pipiens pipiens: 1) 5% permethrin; 2) a mixture of 5% permethrin and 1.5% avermectin; 3) a mixture of 5% permethrin, 1.5% avermectin, and 1% C8,9,10 fatty acids; 4) a mixture of 5% permethrin and 1.5% ivermectin; 5) a mixture of 5% permethrin, 1.5% ivermectin, and 1% C8,9,10 fatty acids. The percentage mortality was recorded at 15 minutes, 1 hour, 24 hours, and 48 hours. The results can be found in Table 9 below.

[0139] Table 9

[0140]

[0141]

[0142] result

[0143] As shown in Table 9 above, application of 5% permethrin only controlled 66.3% of the resistant Culex pipiens pipiens after 48 hours. However, application of a mixture of 5% permethrin and 1.5% avermectin resulted in 91.3% control after 48 hours. This control was improved to 100% by adding 1% C8,9,10 fatty acids. In addition, application of a mixture of 5% permethrin and 1.5% ivermectin resulted in 100% control after 24 hours. The control was not negatively affected by the addition of 1% C8,9,10 fatty acids.

[0144] Example 5 - Control of Culex pipiens quinquefasciatus by a mixture of pyrethroids and avermectin or ivermectin

[0145] method

[0146] In this bioassay, a wind tunnel bioassay was conducted in New Mexico in March 2020. Culex pipiens pipiens, known to be resistant and sensitive to permethrin, was used in the study. The following solutions were applied to adult Culex pipiens pipiens: 1) 1.5% avermectin; 2) 1.5% ivermectin; 3) 5% pyrethrin; 4) a mixture of 5% pyrethrin and 1.5% avermectin; 5) a mixture of 5% pyrethrin and 1.5% ivermectin. The percentage mortality was recorded at 15 minutes, 1 hour, 24 hours, and 48 hours. The results can be found in Table 10 below.

[0147] Table 10

[0148]

[0149] result

[0150] As shown in Table 10 above, application of 5% pyrethrins resulted in only 46.3% control of resistant Culex pipiens quinquefasciatus after 48 hours. Application of 1.5% avermectin or 1.5% ivermectin resulted in 80% and 91.3% control, respectively. However, application of a mixture of 5% pyrethrins and 1.5% avermectin resulted in 96.9% control after 24 hours. In fact, application of a mixture of 5% permethrin and 1.5% avermectin resulted in control of permethrin-resistant Culex pipiens quinquefasciatus at 1 hour, 24 hours, and 48 hours after application, which was unexpected when either insecticide was applied alone. In addition, application of a mixture of 5% pyrethrins and 1.5% ivermectin resulted in 95% control after 48 hours.

[0151] Example 6 - Control of Culex pipiens quinquefasciatus by a mixture of cypermethrin and avermectin

[0152] method

[0153] In this bioassay, an outdoor ultra-low volume study was conducted in June 2020 in New Mexico and October 2020 in Arizona using Culex pipiens pipiens (laboratory-reared) known to be sensitive to permethrin. A solution containing a mixture of 4% cypermethrin, 1.5% avermectin, and 1% C8, 9, 10 fatty acids was applied as a spray to 18 cages, each with 20 adult female Culex pipiens pipiens (n=3), evenly spaced in an open field with low vegetation at 100, 200, and 300 feet from the sprayer. The average wind speed was approximately 4 miles per hour. The percentage mortality was recorded over a 48-hour period. The results can be found in Table 11 below.

[0154] Table 11

[0155]

[0156] result

[0157] As shown in Table 11 above, application of 4% cypermethrin and 1.5% avermectin resulted in nearly 100% kill of susceptible Culex pipiens quinquefasciatus. This efficacy was maintained at a distance of 300 feet from the sprayer. The mortality rate in the uncontrolled group was less than 1.5%.

[0158] Example 7 - Control of pyrethroid-resistant Culex pipiens quinquefasciatus by a mixture of cypermethrin and avermectin

[0159] method

[0160] In this bioassay, an outdoor ultra-low volume study was conducted in New Mexico in August 2020, as described in Example 6 above. Culex pipiens pipiens known to be resistant (Yolo County, California strain) or susceptible (laboratory reared) to permethrin was used in the study. The average wind speed was approximately 4 miles per hour. The percentage mortality was recorded over a 48-hour period. The results can be found in Table 12 below.

[0161] Table 12

[0162]

[0163] result

[0164] As shown in Table 12 above, application of 4% cypermethrin and 1.5% avermectin resulted in nearly 100% of susceptible Culex pipiens pipiens. This efficacy was maintained at a distance of 300 feet from the sprayer. In addition, application of 4% cypermethrin and 1.5% avermectin resulted in nearly 100% of resistant Culex pipiens pipiens. At 300 feet from the sprayer, the efficacy was only slightly lower. The mortality rate in the uncontrolled group was less than 1%.

[0165] Example 8 - Control of Aedes aegypti by a mixture of cypermethrin and avermectin

[0166] method

[0167] In this bioassay, outdoor ultra-low volume studies were conducted in California in July 2020 and Florida in October 2020, as described in Example 6 above. Aedes aegypti (laboratory-reared), known to be sensitive to permethrin, were used in the study. The average wind speed was approximately 3.0 miles per hour. The percentage mortality was recorded over a 48-hour period. The results can be found in Table 13 below.

[0168] Table 13

[0169]

[0170] result

[0171] As shown in Table 13 above, application of 4% cypermethrin and 1.5% avermectin resulted in nearly 100% kill of susceptible Aedes aegypti mosquitoes. This efficacy was maintained at a distance of 300 feet from the sprayer. The mortality rate in the uncontrolled group was less than 1%.

[0172] Example 9 - Control of pyrethroid-resistant Aedes aegypti by a mixture of cypermethrin and avermectin

[0173] method

[0174] In this bioassay, as described in Example 6 above, outdoor ultra-low volume studies were conducted in New Mexico in September (Puerto Rico strain) and November (Florida strain) of 2020. Aedes aegypti mosquitoes known to be resistant (Puerto Rico strain and Florida strain) or sensitive (laboratory-reared) to permethrin were used in the study. The average wind speed was approximately 4 miles per hour. The percentage mortality was recorded over a 48-hour period. The results can be found in Table 14 below.

[0175] Table 14

[0176]

[0177] result

[0178] As shown in Table 14 above, application of 4% cypermethrin and 1.5% avermectin resulted in 100% control of susceptible Aedes aegypti mosquitoes. This efficacy was maintained at a distance of 300 feet from the sprayer. In addition, application of 4% cypermethrin and 1.5% avermectin resulted in control of approximately 94% of resistant Aedes aegypti Puerto Rico strain mosquitoes and nearly 100% of resistant Aedes aegypti Florida strain mosquitoes. At 300 feet from the sprayer, the efficacy was only slightly lower. The mortality rate in the uncontrolled group was less than 1%.

[0179] Example 10 - Control of Anopheles quadrimaculatus by a mixture of cypermethrin and avermectin

[0180] method

[0181] In this bioassay, an outdoor ultra-low volume study was conducted in Texas in October 2020, as described in Example 6 above. Anopheles quadrimaculatus (laboratory-reared), known to be sensitive to permethrin, was used in the study. The average wind speed was approximately 3 miles per hour. The percentage mortality was recorded over a 48-hour period. The results can be found in Table 15 below.

[0182] Table 15

[0183]

[0184] result

[0185] As shown in Table 15 above, application of 4% cypermethrin and 1.5% avermectin resulted in nearly 100% kill of susceptible Anopheles quadrimaculatus. This efficacy was maintained at a distance of 300 feet from the sprayer. The mortality rate in the uncontrolled group was less than 1%.

Claims

1. An insecticidal mixture comprising one or more bacteriocins selected from the group consisting of avermectin and ivermectin, and one or more pyrethroids selected from the group consisting of cypermethrin, permethrin and pyrethrin, wherein the one or more bacteriocins and the one or more pyrethroids are the only insecticidal active ingredients, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is from 3.3:1 to 1.3:

1.

2. The mixture according to claim 1, wherein the one or more bacteriocins are avermectins and the one or more pyrethroids are permethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 3.3:

1.

3. The mixture according to claim 1, wherein the one or more bacteriocins are ivermectin and the one or more pyrethroids are cypermethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 1.3:

1.

4. An insecticidal mixture comprising one or more abamectins selected from the group consisting of avermectin and ivermectin, one or more pyrethroids selected from the group consisting of cypermethrin, permethrin and pyrethrin, and C8, 9, 10 fatty acids, wherein the one or more abamectins, the one or more pyrethroids and the C8, 9, 10 fatty acids are the only insecticidal active ingredients, and wherein the weight ratio of the one or more pyrethroids to the one or more abamectins is from 3.3:1 to 1.3:

1.

5. The mixture according to claim 4, wherein the one or more bacteriocins are avermectins and the one or more pyrethroids are permethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 3.3:

1.

6. The mixture according to claim 4, wherein the one or more bacteriocins are ivermectin and the one or more pyrethroids are cypermethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 1.3:

1.

7. A method for controlling mosquitoes, comprising applying an effective amount of a mixture of one or more bacteriocins selected from avermectin and ivermectin and one or more pyrethroids selected from cypermethrin, permethrin and pyrethrin to the mosquitoes or an area in need of mosquito control, sequentially or simultaneously, wherein the one or more bacteriocins and the one or more pyrethroids are the only insecticidal active ingredients, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 3.3:1 to 1.3:

1.

8. The method of claim 7, wherein the mosquito is selected from the group consisting of Aedes aegypti, Culex pipiens quinquefasciatus, Anopheles quadrimaculatus, and combinations thereof.

9. The method of claim 7, wherein the mosquito is resistant to pyrethroids.

10. The method of claim 7, wherein the area in need of pest control is a mosquito net, a tent or clothing.

11. The method of claim 7, wherein the control is residual.

12. The method of claim 7, wherein the mixture is applied by a technique selected from the group consisting of spraying, brushing, and dipping.

13. The method of claim 7, wherein the one or more bacteriocins are avermectins and the one or more pyrethroids are permethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 3.3:

1.

14. The method of claim 7, wherein the one or more bacteriocins are ivermectin and the one or more pyrethroids are cypermethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 1.3:

1.

15. A method for controlling mosquitoes, comprising applying an effective amount of one or more bacteriocins selected from avermectin and ivermectin, a mixture of one or more pyrethroids selected from cypermethrin, permethrin and pyrethrins, and C8, 9, 10 fatty acids to the mosquitoes or areas where mosquitoes need to be controlled, sequentially or simultaneously, wherein the one or more bacteriocins, the one or more pyrethroids and C8, 9, 10 fatty acids are the only insecticidal active ingredients, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 3.3:1 to 1.3:

1.

16. The method of claim 15, wherein the mosquito belongs to a genus selected from the group consisting of Culex, Aedes, Anopheles, and combinations thereof.

17. The method of claim 15, wherein the one or more bacteriocins are avermectins and the one or more pyrethroids are permethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 3.3:

1.

18. The method of claim 15, wherein the one or more bacteriocins are ivermectin and the one or more pyrethroids are cypermethrin, and wherein the weight ratio of the one or more pyrethroids to the one or more bacteriocins is 1.3:1.

Citation Information

Patent Citations

  • Octanoic, nonanoic and decanoic fatty acids with a pyrethroid adulticide

    US9826742B2

  • A set of insecticide in soluble liquor with fenpropathrin as raw material

    CN1795722A

  • Octanoic, nonanoic and decanoic fatty acids with a pyrethroid adulticide

    US20150094367A1